SciClone Pharmaceuticals, Inc. (SCLN)

[hayloft999]

I got burned badly with GNTA but if zadaxin is less toxic than genasense and reaches it's primary endpoint (which may be overall survival benefit) then this has got a good chance of approval at ODAC and then $10 is a definite possibility.

For speculating terms I suppose Phase 3 trials could be started by 2nd quarter next year and then we could be looking at ODAC 2008 sometime if the phase 3 trials look good!

GLTY